2
Clinical Trials associated with GH509GH509对比安慰剂治疗非酒精性脂肪性肝炎(NASH)/非酒精性脂肪性肝病(NAFLD)患者的有效性和安全性的Ib期临床研究
[Translation] Phase Ib clinical study of the efficacy and safety of GH509 versus placebo in patients with non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD)
[Translation] Phase Ib trial:
Select the Phase II recommended dose of GH509.
Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)/Non-alcoholic Fatty Liver Disease (NAFLD)
This is a Phase Ib/II, randomized, double-blind, placebo-controlled, international multi-center clinical study to investigate the efficacy and safety of GH509 in subjects with NASH/NAFLD
100 Clinical Results associated with GH509
100 Translational Medicine associated with GH509
100 Patents (Medical) associated with GH509
100 Deals associated with GH509